Prostate Cancer - Results from #24360

Changes in apparent diffusion coefficient and T(2) relaxation during radiotherapy for prostate cancer - Abstract November 21, 2012

Interstitial brachytherapy in localized prostate cancer – update: Executive summary of final report N10-01, Version 1.0 - Abstract November 21, 2012

Diabetes mellitus and prostate cancer risk in Asian countries: A meta-analysis - Abstract November 21, 2012

Cabazitaxel (Jevtana): A novel agent for metastatic castration-resistant prostate cancer - Abstract November 20, 2012

Contemporary grading for prostate cancer: Implications for patient care - Abstract November 20, 2012

A biodistribution and toxicity study of cobalt dichloride-N-acetyl cysteine in an implantable MRI marker for prostate cancer treatment - Abstract November 20, 2012

Androgen receptor signaling in circulating tumor cells as a marker of hormonally responsive prostate cancer - Abstract November 20, 2012

The potential of circulating tumor cells as a liquid biopsy to guide therapy in prostate cancer - Abstract November 20, 2012

Challenging the 10-year rule: The accuracy of patient life expectancy predictions by physicians in relation to prostate cancer management - Abstract November 20, 2012

Efficacy versus effectiveness study design within the European screening trial for prostate cancer: Consequences for cancer incidence, overall mortality and cancer-specific mortality - Abstract November 20, 2012

Anti-angiogenic therapies in prostate cancer - Abstract November 20, 2012

Partial sampling of radical prostatectomy specimens: Detection of positive margins and extraprostatic extension - Abstract November 20, 2012

Prospective study on metabolic factors and risk of prostate cancer - Abstract November 20, 2012

Androgen metabolism gene polymorphisms, associations with prostate cancer risk and pathological characteristics: A comparative analysis between South African and Senegalese men - Abstract November 20, 2012

Association of obesity and diabetes with serum prostate-specific antigen levels in Japanese males - Abstract November 20, 2012

The REDUCE metagram: A comprehensive prediction tool for determining the utility of dutasteride chemoprevention in men at risk for prostate cancer - Abstract November 19, 2012

Low incidence of fatigue after hypofractionated stereotactic body radiation therapy for localized prostate cancer - Abstract November 19, 2012

Geometric evaluation of systematic transrectal ultrasound guided prostate biopsy - Abstract November 19, 2012

Complications of laparoscopic radical prostatectomy-a single institute experience - Abstract November 19, 2012

Strength training induces muscle hypertrophy and functional gains in Black prostate cancer patients despite androgen deprivation therapy - Abstract November 19, 2012

Page 1219 of 1435